Trial intelligence / Profile preview

Hypertonic saline infusion to reduce high intraocular pressure before eye surgery

2012-005025-70Phase 4Completed

Sponsor
Helsinki University Hospital
Start
Nov 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of hypertonic saline in ocular hypertension, Glaucoma and cataract (2 arms), sponsored by Helsinki University Hospital. Primary endpoint: Eyepressure after NaCl bolus or mannitol infusion (primary). Started Nov 2012; status: completed.

02

Drugs

hypertonic saline
03

Conditions

ocular hypertensionGlaucomacataract

Beyond the preview

Go deeper on 2012-005025-70.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-005025-70.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call